Treatment of Down syndrome: the target was found, it remains to get into it
In mice with Down syndrome, in whose brains the human protein SNX27 was introduced by gene therapy, an increase in the number of glutamate receptors and normalization of brain functions were observed. However, the use of such a technique in relation to people is still far away.
26.03.2013